[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_17101 

# __Lack of evidence-based research on the recommended use of anti-inflammatory drugs for covid-19 treatment__

## Articles mentionning the risk

* [Orso_infodemic_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_622.md)

## Mitigations of this risk

* [Investment in research and clinical trials to provide clear guidance on the use of anti-inflammatory drugs for covid-19](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_19054.md)

## Name of the risk

Uncertainty and confusion among medical professionals and the general public regarding the most effective treatment options

## People affected by this risk

* [Healthcare providers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_31.md)
* [Medical researchers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_121.md)
* [Patients](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_685.md)

## Stakeholders who can mitigate this risk

* [Healthcare organizations](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_216.md)
* [Pharmaceutical companies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_413.md)
* [Research institutions](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_124.md)

## Technologies linked to the risk

* [Biomedical databases](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_19459.md)
* [Clinical research tools](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_19460.md)

## This Risk belongs to this RiskGroup

* [Public health risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_3.md)

## This Risk belongs to this RiskSubgroup

* [Misinterpretation of data and results](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_3.md)

